Neogen (NEOG) Non-Current Deferred Tax Liability (2011 - 2026)

Neogen (NEOG) recorded quarterly Non-Current Deferred Tax Liability of $269.2 million in Q1 2026, down 1.73% quarter-over-quarter from $273.9 million in Q4 2025, and down 10.58% on a YoY basis from $301.1 million in Q1 2025.

Neogen (NEOG) Non-Current Deferred Tax Liability (2011 - 2026) Analysis & Trends

Neogen's Non-Current Deferred Tax Liability history runs 16 years deep, the most recent figure standing at $269.2 million for Q1 2026.

  • In Q1 2026, Non-Current Deferred Tax Liability fell 10.58% year-over-year to $269.2 million; the TTM figure through Feb 2026 stood at $269.2 million (down 10.58% YoY), while the FY2025 annual figure was $280.9 million, down 14.02% from the prior year.
  • Non-Current Deferred Tax Liability was $269.2 million for Q1 2026 at Neogen, down from $273.9 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $364.3 million in Q4 2022 to a low of $15.9 million in Q3 2022.
  • Historically, Non-Current Deferred Tax Liability has averaged $267.5 million across 5 years, with a median of $302.4 million in 2024.
  • The sharpest annual moves came in 2022 and 2023: Non-Current Deferred Tax Liability tumbled 34.59% in 2022, then soared 2124.54% in 2023.
  • A 5-year view of Non-Current Deferred Tax Liability shows it stood at $364.3 million in 2022, then declined by 2.54% to $355.0 million in 2023, then retreated by 14.82% to $302.4 million in 2024, then slipped by 9.41% to $273.9 million in 2025, then retreated by 1.73% to $269.2 million in 2026.
  • The last three Non-Current Deferred Tax Liability figures came in at $269.2 million (Q1 2026), $273.9 million (Q4 2025), and $277.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Neogen 2.03 Bn 1.87 Bn 99.00 Mn

Historic Data

Download Data
DateValue
Feb 28, 2026 269.20 Mn
Feb 28, 2026 269.20 Mn
Nov 30, 2025 273.95 Mn
Nov 30, 2025 273.95 Mn
Aug 31, 2025 277.25 Mn
Aug 31, 2025 277.25 Mn
May 31, 2025 280.90 Mn
May 31, 2025 280.90 Mn
Feb 28, 2025 301.05 Mn
Feb 28, 2025 301.05 Mn
Nov 30, 2024 302.41 Mn
Nov 30, 2024 302.41 Mn
Aug 31, 2024 317.57 Mn
Aug 31, 2024 317.57 Mn
May 31, 2024 326.72 Mn
May 31, 2024 326.72 Mn
Feb 29, 2024 353.85 Mn
Feb 29, 2024 353.85 Mn
Nov 30, 2023 355.01 Mn
Nov 30, 2023 355.01 Mn